Jeff Till Email & Phone Number
Who is Jeff Till? Overview
A concise factual answer block for searchers comparing this professional profile.
Jeff Till is listed as Director, Search and Evaluation, Cell Therapy and Rare Disease at Novo Nordisk, a with 66807 employees, based in Greater Boston, United States. AeroLeads shows a matched LinkedIn profile for Jeff Till.
Jeff Till previously worked as Director, Search & Evaluation, Cell Therapy at Novo Nordisk and Head of Scientific Competitive Intelligence & Knowledge Management at Emd Serono, Inc.. Jeff Till holds Phd, Molecular And Cellular Biochemistry from State University Of New York At Stony Brook.
Email format at Novo Nordisk
This section adds company-level context without repeating Jeff Till's masked contact details.
Review company-level records connected to Jeff Till before choosing the right outreach path.
About Jeff Till
With over 20 years of experience in the biopharmaceutical and life science industry, I am passionate about driving innovation and excellence in R&D, external innovation, and competitive intelligence. My mission is to leverage my expertise in molecular and cellular biochemistry, digital/AI technologies, and cell therapy to identify, evaluate, and acquire cutting-edge solutions that can advance the science and improve the lives of patients.
Jeff Till's current company
Company context helps verify the profile and gives searchers a useful next step.
Jeff Till work experience
A career timeline built from the work history available for this profile.
Director, Search & Evaluation, Cell Therapy
CurrentLooking for strategic technologies, assets and devices to help advance Novo Nordisk's cell therapy programs. Part of Corporate Development in partnership with R&D.
Head Of Scientific Competitive Intelligence & Knowledge Management
Established the R&D function for Competitive Intelligence & Knowledge Management, aimed at streamlining access to comprehensive competitive intelligence for informed decision-making in R&D, technology search, evaluation opportunities, and business negotiations.
Head Of Search And Evaluation – Digital / Ai Technologies
Created and established new function within External Innovation to create a necessary focal point for search, evaluation, and acquisition of differentiating computational technologies in a rapidly evolving landscape with multiple internal stakeholders across the organization.
Head, Cell And Gene Therapy - External Innovation
Head of Intrexon*:EMD Serono collaboration to develop novel CAR-T cell therapeutics for Oncology and lead for cell therapy business strategy and development. (*now Precigen)
Director, Global Licensing & Business Development
One-year rotational assignment where directed scouting, evaluation, and business transactions to drive high value opportunities that advance the pre-clinical and clinical pipeline.
Global Head, Cross Division Innovation – External Innovation
Inter-division collaboration lead between EMD Life Sciences and EMD Healthcare.
Sr. Director, Science & Technology
Director, Innovation And Strategy – Stem Cell Innovation Program
Bioscience division business lead for new business opportunities in stem cell scale-up and manufacturing, and applications for drug discovery and regenerative medicine.
Director, Strategic Marketing
Scientific Director
Scientist, Drug Discovery
Colleagues at Novo Nordisk
Other employees you can reach at novonordisk.com. View company contacts for 66807 employees →
Syukri Shamsudin
Colleague at Novo NordiskZurich, Switzerland
View →
MB
Maria Bille
Colleague at Novo NordiskCopenhagen, Capital Region Of Denmark, Denmark
View →
MT
Michael Thun Klausen
Colleague at Novo NordiskHillerød, Capital Region Of Denmark, Denmark
View →
AK
Anders Kaae
Colleague at Novo NordiskRegion Zealand, Denmark
View →
EA
Esma Avsever
Colleague at Novo NordiskCopenhagen, Capital Region Of Denmark, Denmark
View →
CO
Christian Ong Hansen
Colleague at Novo NordiskFarum, Capital Region Of Denmark, Denmark
View →
JR
Julieta Rio
Colleague at Novo NordiskArgentina
View →
BE
Berit Eskerod Olsen
Colleague at Novo NordiskKalundborg, Region Zealand, Denmark
View →
CL
Christoffer Laisen
Colleague at Novo NordiskCopenhagen, Capital Region Of Denmark, Denmark
View →
CW
Corinne Weideli Hansen
Colleague at Novo NordiskDenmark
View →
Jeff Till education
Frequently asked questions about Jeff Till
Quick answers generated from the profile data available on this page.
What company does Jeff Till work for?
Jeff Till works for Novo Nordisk.
What is Jeff Till's role at Novo Nordisk?
Jeff Till is listed as Director, Search and Evaluation, Cell Therapy and Rare Disease at Novo Nordisk.
Where is Jeff Till based?
Jeff Till is based in Greater Boston, United States while working with Novo Nordisk.
What companies has Jeff Till worked for?
Jeff Till has worked for Novo Nordisk, Emd Serono, Inc., Emd Serono, Emd Millipore, and Millipore.
Who are Jeff Till's colleagues at Novo Nordisk?
Jeff Till's colleagues at Novo Nordisk include Syukri Shamsudin, Maria Bille, Michael Thun Klausen, Anders Kaae, and Esma Avsever.
How can I contact Jeff Till?
You can use AeroLeads to view verified contact signals for Jeff Till at Novo Nordisk, including work email, phone, and LinkedIn data when available.
What schools did Jeff Till attend?
Jeff Till holds Phd, Molecular And Cellular Biochemistry from State University Of New York At Stony Brook.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Jeff Till you were looking for.
View similar profiles